防御:探索它们在结肠直肠癌进展中的对立作用
Hussein Sabit1, Timothy M Pawlik2, Shaimaa Abdel-Ghany3
1Department of Medical Biotechnology, College of Biotechnology, Misr University for Science and Technology, Giza P.O. Box 77, Egypt.
Cancers
|August 10, 2024
概括
人类β-防御素1 (HBD-1) 可能影响结肠直肠癌 (CRC) 的发展和进展. 这篇评论探讨了HBD-1的情况.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 分子生物学分子生物学
背景情况:
- 结肠直肠癌 (CRC) 发病率正在上升,特别是在年轻人中,这表明与饮食和肠道微生物组的联系.
- PI3K/AKT/mTOR通路是细胞生长的关键调节者,也是CRC中潜在的治疗点.
- 防御素,像人类β-防御素1 (HBD-1),具有抗菌性质,可能在CRC中发挥作用.
研究的目的:
- 审查了解HBD-1如何影响CRC启动和进展的最新进展.
- 要突出HBD-1影响CRC的分子机制.
- 描述 CRC 中的防御素和 mTOR 途径之间的相互作用.
主要方法:
- 关于HBD-1和CRC的最近研究的文献综述.
- 对将HBD-1与CRC联系起来的分子机制的分析.
- 检查防御素与结直肠癌中的mTOR途径之间的相互作用.
主要成果:
- 人们越来越认识到HBD-1在CRC发病和进展中的作用.
- 正在阐明HBD-1对CRC影响的特定分子机制.
- 防御素与mTOR通路之间的相互作用在CRC发育中至关重要.
结论:
- 了解HBD-1在CRC中的功能为改善诊断和治疗提供了潜力.
- 向HBD-1和mTOR途径可能代表结直肠癌的新疗法策略.
- 对CRC中防御素表达模式的进一步研究是有必要的.
相关概念视频
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Renewal of Intestinal Stem Cells
2.5K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K


